Greenwich Lifesciences Stock Investor Sentiment

GLSI Stock  USD 12.21  0.21  1.75%   
Under 60% of all Greenwich Lifesciences' traders are looking to take a long position. The analysis of the overall investor sentiment regarding Greenwich Lifesciences suggests that some traders are interested. Greenwich Lifesciences' investing sentiment shows overall attitude of investors towards Greenwich Lifesciences.

Comfort Level 60

 Interested

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Greenwich Lifesciences' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Greenwich Lifesciences.

Greenwich Historical Sentiment

Although Greenwich Lifesciences' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Greenwich, such as negative comments on social media and news outlets, may cause fear in the market and push Greenwich Lifesciences' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Greenwich.
  

Greenwich Lifesciences Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Greenwich Lifesciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Greenwich Lifesciences Historical Investor Sentiment

Investor biases related to Greenwich Lifesciences' public news can be used to forecast risks associated with an investment in Greenwich. The trend in average sentiment can be used to explain how an investor holding Greenwich can time the market purely based on public headlines and social activities around Greenwich Lifesciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Greenwich Lifesciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Greenwich Lifesciences and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Greenwich Lifesciences news discussions. The higher the estimate score, the more favorable the investor's outlook on Greenwich Lifesciences.
23 hours ago at gurufocus.com         
Greenwich LifeSciences Provides Update on Open Label Safety Data from FLAMINGO-01
Gurufocus Stories at Macroaxis
few days ago at www.macroaxis.com         
Acquisition by Jaye Thompson of 149818 shares of Greenwich Lifesciences at 12.16 subject to Rule 16b...
Macroaxis News
six days ago at news.google.com         
Trading With Integrated Risk Controls - Stock Traders Daily
Google News at Macroaxis
over a week ago at www.macroaxis.com         
Acquisition by Snehal Patel of 12000 shares of Greenwich Lifesciences at 8.33 subject to Rule 16b-3
Macroaxis News
over a week ago at finance.yahoo.com         
55 percent of Greenwich LifeSciences, Inc. is owned by insiders, and theyve been buying recently
Yahoo News
over two weeks ago at news.google.com         
Learn to Evaluate using the Charts - Stock Traders Daily
Google News at Macroaxis
over two weeks ago at www.macroaxis.com         
Acquisition by Snehal Patel of 2000 shares of Greenwich Lifesciences at 9.72 subject to Rule 16b-3
Macroaxis News
over three weeks ago at news.google.com         
Greenwich LifeSciences, Inc. Sees Large Increase in Short Interest - MarketBeat
Google News at Macroaxis
over three weeks ago at news.google.com         
FY2024 Earnings Estimate for GLSI Issued By HC Wainwright - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
Greenwich LifeSciences Earns Buy Rating from HC Wainwright - MarketBeat
Google News at Macroaxis
over a month ago at prnewswire.com         
SHAREHOLDER ALERT Purcell Lefkowitz LLP Announces Shareholder Investigation of Greenwich LifeScience...
prnewswire News
over a month ago at globenewswire.com         
Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01
Macroaxis News: globenewswire.com
over a month ago at gurufocus.com         
Greenwich LifeSciences Provides Update on Open Label HLA Data fr
Gurufocus Stories at Macroaxis
over a month ago at news.google.com         
Technical Pivots with Risk Controls - Stock Traders Daily
Google News at Macroaxis
over a month ago at news.google.com         
Major Breakthrough Cancer Prevention Trial Goes Europe-Wide as Top Medical Centers Join Forces - Sto...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Greenwich Lifesciences that are available to investors today. That information is available publicly through Greenwich media outlets and privately through word of mouth or via Greenwich internal channels. However, regardless of the origin, that massive amount of Greenwich data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Greenwich Lifesciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Greenwich Lifesciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Greenwich Lifesciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Greenwich Lifesciences alpha.

Greenwich Lifesciences Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Acquisition by Mcwilliams David of 61984 shares of Greenwich Lifesciences at 12.16 subject to Rule 16b-3
12/24/2024
2
Acquisition by Snehal Patel of 3200 shares of Greenwich Lifesciences at 11.12 subject to Rule 16b-3
12/30/2024
3
Insider Purchases Worth US3.19m See Losses As Greenwich LifeSciences Market Value Drops To US151m
12/31/2024
4
Acquisition by Snehal Patel of 2500 shares of Greenwich Lifesciences at 12.51 subject to Rule 16b-3
01/10/2025
5
Greenwich LifeSciences Partners with Unicancer Expanding Flaming
01/13/2025
6
Glancy Prongay Murray LLP Announces Investigation of Greenwich LifeSciences, Inc.
01/17/2025
7
Bullish Greenwich LifeSciences Insiders Loaded Up On US3.39m Of Stock - Yahoo Finance
01/23/2025
8
Greenwich LifeSciences Approved to Add Additional Sites to FLAMINGO-01 in Europe
01/29/2025
9
Technical Pivots with Risk Controls - Stock Traders Daily
02/06/2025
10
SHAREHOLDER ALERT Purcell Lefkowitz LLP Announces Shareholder Investigation of Greenwich LifeSciences, Inc.
02/11/2025
11
Acquisition by Snehal Patel of 2000 shares of Greenwich Lifesciences at 9.72 subject to Rule 16b-3
02/25/2025
12
55 percent of Greenwich LifeSciences, Inc. is owned by insiders, and theyve been buying recently
03/05/2025
13
Acquisition by Snehal Patel of 12000 shares of Greenwich Lifesciences at 8.33 subject to Rule 16b-3
03/06/2025
14
Acquisition by Jaye Thompson of 149818 shares of Greenwich Lifesciences at 12.16 subject to Rule 16b-3
03/13/2025

Complementary Tools for Greenwich Stock analysis

When running Greenwich Lifesciences' price analysis, check to measure Greenwich Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Greenwich Lifesciences is operating at the current time. Most of Greenwich Lifesciences' value examination focuses on studying past and present price action to predict the probability of Greenwich Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Greenwich Lifesciences' price. Additionally, you may evaluate how the addition of Greenwich Lifesciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Commodity Directory
Find actively traded commodities issued by global exchanges
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.